查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631247

定量吸入器的全球市场 - 全球产业分析，规模，占有率，成长，趋势，预测(2032年)

Metered Dose Inhalers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032
出版日期: | 出版商: Fairfield Market Research | 英文 186 Pages | 商品交期: 2-5个工作天内

价格
简介目录

全球定量吸入器市场规模将显着成长，复合年增长率为 4.9%，预计将从 2025 年的 310.3 亿美元增长到 2032 年的 433.5 亿美元。 MDI 在呼吸药物传递中发挥着至关重要的作用，可确保精确且可控地管理气喘和慢性阻塞性肺病 (COPD) 等疾病的药物。

定量吸入器是一种紧凑的手持设备，旨在有效地输送雾化药物。它的便携性、易用性和准确性使其成为管理呼吸系统疾病的重要工具。全球呼吸系统疾病病例的增加和吸入器技术的进步正在推动对 MDI 的需求。

吸入器设计和配方的创新是主要的成长动力。製药公司和研究机构之间的合作为整合数位技术和感测器的智慧吸入器铺平了道路，以提高患者的依从性并实现个人化治疗。气喘、慢性阻塞性肺病和其他呼吸系统疾病的增加推动了对有效吸入疗法的需求。 MDI 现在具有使用者友好的设计和数位解决方案，可提高患者参与度并改善对规定治疗的依从性。

连网设备和数位健康平台的兴起为全球定量吸入器市场提供了重大机会。嵌入感测器的智慧吸入器可以提供药物使用的即时数据，使医疗保健提供者能够调整治疗策略并改善患者的治疗效果。这些设备还透过行动应用程式提供的回馈、提醒和教育工具为患者提供支援。

本报告提供全球定量吸入器市场相关调查，提供市场概要，以及各类型，各终端用户，及各地区趋势，及市场参与市场企业的竞争趋势等资讯。

目录

第1章 摘要整理

第2章 市场概要

  • 市场定义和市场区隔
  • 市场动态
  • 价值链分析
  • 波特的五力分析
  • COVID-19影响分析
  • 乌克兰·俄罗斯纠纷的影响
  • 经济概要
  • 大环境分析

第3章 价格分析，2019年～2023年

第4章 全球定量吸入器市场预测，2019年～2032年

  • 全球定量吸入器市场预测，各类型，金额(10亿美元)，数量(100万台)，2019年～2032年
  • 全球定量吸入器市场预测，各终端用户，金额(10亿美元)，数量(100万台)，2019年～2032年
  • 全球定量吸入器市场预测，各地区，金额(10亿美元)，数量(100万台)，2019年～2032年

第5章 北美的定量吸入器市场预测，2019年～2032年

第6章 欧洲的定量吸入器市场预测，2019年～2032年

第7章 亚太地区的定量吸入器市场预测，2019年～2032年

第8章 南美的定量吸入器市场预测，2019年～2032年

第9章 中东·非洲的定量吸入器市场预测，2019年～2032年

第10章 竞争情形

  • 类型和终端用户的热图
  • 企业市场占有率分析，2024年
  • 竞争仪表板
  • 企业简介
    • Cipla Inc.
    • Presspart Manufacturing Ltd.
    • Midascare Pharmaceuticals Pvt. Ltd.
    • Beximco Pharma Ltd.
    • GlaxoSmithKline Pharmaceuticals Ltd.
    • 3M Pharmaceuticals Pty Ltd.
    • Biocare Manufacturing Sdn Bhd.
    • Anomatic Innovation & Design Center & Manufacturing
    • Aristo Pharma Ltd.

第11章 附录

简介目录

The global metered dose inhalers market is on track for notable growth, with a projected compound annual growth rate (CAGR) of 4.9%. It is anticipated to grow from USD 31.03 billion in 2025 to USD 43.35 billion by 2032. MDIs play a pivotal role in respiratory drug delivery, ensuring precise and controlled administration of medication for conditions like asthma and chronic obstructive pulmonary disease (COPD).

Metered dose inhalers are compact, handheld devices designed to effectively deliver aerosolized medication. Their portability, ease of use, and precision make them essential tools in managing respiratory disorders. Increasing cases of respiratory diseases worldwide, along with advancements in inhaler technology, have significantly driven the demand for MDIs.

Key Market Drivers

  • 1.Technological Advancements: Innovation in inhaler design and formulation has been a major growth factor. Collaborations between pharmaceutical firms and research institutions have paved the way for intelligent inhalers integrated with digital technology and sensors, improving patient adherence and enabling personalized treatments.
  • 2.Rising Respiratory Disease Burden: Growing incidences of asthma, COPD, and other respiratory disorders are driving the demand for effective inhalation therapies.
  • 3.Patient-Centric Features: The inclusion of user-friendly designs and digital solutions in MDIs has enhanced patient engagement and adherence to prescribed treatments.

Business Opportunities

The rise of connected devices and digital health platforms presents significant opportunities in the global metered dose inhalers market. Smart inhalers embedded with sensors provide real-time data on medication usage, enabling healthcare providers to tailor treatment strategies and enhance patient outcomes. These devices also empower patients through feedback, reminders, and educational tools available via mobile apps.

Market Restraints

  • 1.Environmental Concerns: Conventional MDIs depend on hydrofluoroalkane (HFA) propellants, which have high global warming potential. Regulatory efforts are urging manufacturers to transition to more eco-friendly alternatives.
  • 2.Regulatory Challenges: Complex and evolving regulatory requirements for new inhaler technologies pose significant hurdles for manufacturers, necessitating rigorous validation and compliance efforts.

Regional Analysis

  • 1.Asia Pacific: The region is expected to lead the market, driven by a large population base with a high prevalence of respiratory conditions. Countries like China and India are seeing increased adoption of advanced respiratory therapies due to better healthcare infrastructure and economic growth.
  • 2.Latin America: The fastest-growing region, Latin America's market expansion is propelled by rising awareness of respiratory health, improved healthcare facilities, and access to advanced inhaler technologies.
  • 3.North America and Europe: These regions remain major markets due to high healthcare spending and advanced infrastructure, although the Asia Pacific region is emerging as a critical growth area for industry players.

Competitive Analysis

The metered dose inhalers market is highly competitive, with leading players focusing on innovation, partnerships, and global expansion to strengthen their market presence. Key companies include:

  • Cipla Inc.
  • Presspart Manufacturing Ltd.
  • Midascare Pharmaceuticals Pvt. Ltd.
  • Beximco Pharma Ltd.
  • GlaxoSmithKline Pharmaceuticals Ltd.
  • 3M Pharmaceuticals Pty Ltd.
  • Biocare Manufacturing Sdn Bhd.
  • Anomatic Innovation & Design Center & Manufacturing
  • Aristo Pharma Ltd.

Metered Dose Inhalers Market Segmentation

  • By Type:
  • Reliever Inhaler
  • Long-acting Bronchodilator Inhaler
  • By End Use:
  • Homecare
  • Hospitals
  • Clinics
  • By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Metered Dose Inhalers Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2019 - 2023

  • 3.1. Global Average Price Analysis, by Type, US$ Per Unit, 2019 - 2023
  • 3.2. Prominent Factor Affecting Metered Dose Inhalers Prices
  • 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Metered Dose Inhalers Market Outlook, 2019 - 2032

  • 4.1. Global Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Reliever Inhaler
      • 4.1.1.2. Long-acting bronchodilators Inhaler
  • 4.2. Global Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Homecare
      • 4.2.1.2. Hospitals
      • 4.2.1.3. Clinics
  • 4.3. Global Metered Dose Inhalers Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. North America
      • 4.3.1.2. Europe
      • 4.3.1.3. Asia Pacific
      • 4.3.1.4. Latin America
      • 4.3.1.5. Middle East & Africa

5. North America Metered Dose Inhalers Market Outlook, 2019 - 2032

  • 5.1. North America Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Reliever Inhaler
      • 5.1.1.2. Long-acting bronchodilators Inhaler
  • 5.2. North America Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Homecare
      • 5.2.1.2. Hospitals
      • 5.2.1.3. Clinics
  • 5.3. North America Metered Dose Inhalers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. U.S. Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 5.3.1.2. U.S. Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 5.3.1.3. Canada Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 5.3.1.4. Canada Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Metered Dose Inhalers Market Outlook, 2019 - 2032

  • 6.1. Europe Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Reliever Inhaler
      • 6.1.1.2. Long-acting bronchodilators Inhaler
  • 6.2. Europe Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Homecare
      • 6.2.1.2. Hospitals
      • 6.2.1.3. Clinics
  • 6.3. Europe Metered Dose Inhalers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Germany Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.2. Germany Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.3. U.K. Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.4. U.K. Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.5. France Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.6. France Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.7. Italy Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.8. Italy Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.9. Turkey Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.10. Turkey Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.11. Russia Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.12. Russia Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.13. Rest of Europe Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 6.3.1.14. Rest of Europe Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Metered Dose Inhalers Market Outlook, 2019 - 2032

  • 7.1. Asia Pacific Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Reliever Inhaler
      • 7.1.1.2. Long-acting bronchodilators Inhaler
  • 7.2. Asia Pacific Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Homecare
      • 7.2.1.2. Hospitals
      • 7.2.1.3. Clinics
  • 7.3. Asia Pacific Metered Dose Inhalers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. China Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.2. China Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.3. Japan Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.4. Japan Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.5. South Korea Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.6. South Korea Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.7. South Korea Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.8. India Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.9. India Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.10. Southeast Asia Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.11. Southeast Asia Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.12. Rest of Asia Pacific Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 7.3.1.13. Rest of Asia Pacific Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Metered Dose Inhalers Market Outlook, 2019 - 2032

  • 8.1. Latin America Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Reliever Inhaler
      • 8.1.1.2. Long-acting bronchodilators Inhaler
  • 8.2. Latin America Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Homecare
      • 8.2.1.2. Hospitals
      • 8.2.1.3. Clinics
  • 8.3. Latin America Metered Dose Inhalers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Brazil Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.2. Brazil Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.3. Mexico Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.4. Mexico Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.5. Argentina Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.6. Argentina Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.7. Rest of Latin America Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 8.3.1.8. Rest of Latin America Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Metered Dose Inhalers Market Outlook, 2019 - 2032

  • 9.1. Middle East & Africa Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.1.1. Key Highlights
      • 9.1.1.1. Reliever Inhaler
      • 9.1.1.2. Long-acting bronchodilators Inhaler
  • 9.2. Middle East & Africa Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.2.1. Key Highlights
      • 9.2.1.1. Homecare
      • 9.2.1.2. Hospitals
      • 9.2.1.3. Clinics
  • 9.3. Middle East & Africa Metered Dose Inhalers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1. Key Highlights
      • 9.3.1.1. GCC Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.2. GCC Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.3. South Africa Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.4. South Africa Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.5. Egypt Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.6. Egypt Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.7. Nigeria Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.8. Nigeria Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.9. Rest of Middle East & Africa Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
      • 9.3.1.10. Rest of Middle East & Africa Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

  • 10.1. Type vs End User Heatmap
  • 10.2. Company Market Share Analysis, 2024
  • 10.3. Competitive Dashboard
  • 10.4. Company Profiles
    • 10.4.1. Cipla Inc.
      • 10.4.1.1. Company Overview
      • 10.4.1.2. Product Portfolio
      • 10.4.1.3. Financial Overview
      • 10.4.1.4. Business Strategies and Development
    • 10.4.2. Presspart Manufacturing Ltd.
      • 10.4.2.1. Company Overview
      • 10.4.2.2. Product Portfolio
      • 10.4.2.3. Financial Overview
      • 10.4.2.4. Business Strategies and Development
    • 10.4.3. Midascare Pharmaceuticals Pvt. Ltd.
      • 10.4.3.1. Company Overview
      • 10.4.3.2. Product Portfolio
      • 10.4.3.3. Financial Overview
      • 10.4.3.4. Business Strategies and Development
    • 10.4.4. Beximco Pharma Ltd.
      • 10.4.4.1. Company Overview
      • 10.4.4.2. Product Portfolio
      • 10.4.4.3. Financial Overview
      • 10.4.4.4. Business Strategies and Development
    • 10.4.5. GlaxoSmithKline Pharmaceuticals Ltd.
      • 10.4.5.1. Company Overview
      • 10.4.5.2. Product Portfolio
      • 10.4.5.3. Financial Overview
      • 10.4.5.4. Business Strategies and Development
    • 10.4.6. 3M Pharmaceuticals Pty Ltd.
      • 10.4.6.1. Company Overview
      • 10.4.6.2. Product Portfolio
      • 10.4.6.3. Financial Overview
      • 10.4.6.4. Business Strategies and Development
    • 10.4.7. Biocare Manufacturing Sdn Bhd.
      • 10.4.7.1. Company Overview
      • 10.4.7.2. Product Portfolio
      • 10.4.7.3. Financial Overview
      • 10.4.7.4. Business Strategies and Development
    • 10.4.8. Anomatic Innovation & Design Center & Manufacturing
      • 10.4.8.1. Company Overview
      • 10.4.8.2. Product Portfolio
      • 10.4.8.3. Financial Overview
      • 10.4.8.4. Business Strategies and Development
    • 10.4.9. Aristo Pharma Ltd.
      • 10.4.9.1. Company Overview
      • 10.4.9.2. Product Portfolio
      • 10.4.9.3. Financial Overview
      • 10.4.9.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations